Q3 2024 13F Holders as of 9/30/2024
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
16.7M
-
Number of holders
-
19
-
Total 13F shares, excl. options
-
3.32M
-
Shares change
-
+45.6K
-
Total reported value, excl. options
-
$21.4M
-
Value change
-
+$304K
-
Number of buys
-
5
-
Number of sells
-
-8
-
Price
-
$6.45
Significant Holders of Coya Therapeutics, Inc. - Common Stock, par value $0.0001 per share (COYA) as of Q3 2024
21 filings reported holding COYA - Coya Therapeutics, Inc. - Common Stock, par value $0.0001 per share as of Q3 2024.
Coya Therapeutics, Inc. - Common Stock, par value $0.0001 per share (COYA) has 19 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 3.32M shares
of 16.7M outstanding shares and own 19.87% of the company stock.
Largest 10 shareholders include DME Capital Management, LP (1.27M shares), VANGUARD GROUP INC (845K shares), AIGH Capital Management LLC (649K shares), CM Management, LLC (144K shares), GEODE CAPITAL MANAGEMENT, LLC (142K shares), BlackRock, Inc. (65.8K shares), STATE STREET CORP (43K shares), PRELUDE CAPITAL MANAGEMENT, LLC (35.8K shares), GHP Investment Advisors, Inc. (26.2K shares), and NORTHERN TRUST CORP (25.5K shares).
This table shows the top 19 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.